Urothelial cancer
31 – 40 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
-
Mark
The Importance of Being Grade 3 : A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non–muscle-invasive Bladder Cancer
- Contribution to journal › Article
-
Mark
Re : Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
- Contribution to journal › Scientific review
-
Mark
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility
- Contribution to journal › Article
- 2023
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
- Contribution to journal › Letter
-
Mark
Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
- Contribution to journal › Article
-
Mark
International Opinions on Grading of Urothelial Carcinoma : A Survey Among European Association of Urology and International Society of Urological Pathology Members
- Contribution to journal › Article
-
Mark
Tumor Biomarkers for Bacillus Calmette-Guérin Response : What We Get Is Not What We Want
- Contribution to journal › Debate/Note/Editorial
